1. |
Seiler A, Jenewein J. Resilience in cancer patients. Front Psychiatry 2019;10:208.
|
2. |
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359-86.
|
3. |
Dastgiri S, Fozounkhah S, Shokrgozar S, Taghavinia M, Asvadi Kermani A. Incidence of leukemia in the Northwest of Iran. Health Promot Perspect 2011;1:50-3.
|
4. |
Belson M, Kingsley B, Holmes A. Risk factors for acute leukemia in children: A review. Environ Health Perspect 2007;115:138-45.
|
5. |
Ghasemi A, Rostami S, Chahardouli B, Alizad Ghandforosh N, Ghotaslou A, Nadali F. Study of SFRP1 and SFRP2 methylation status in patients with de novo acute myeloblastic leukemia. Int J Hematol Oncol Stem Cell Res 2015;9:15-21.
|
6. |
Alizad Ghandforoush N, Chahardouli B, Rostami S, Ghadimi H, Ghasemi A, Alimoghaddam K, et al. Evaluation of minimal residual disease in acute myeloid leukemia with NPM1 marker. Int J Hematol Oncol Stem Cell Res 2016;10:147-52.
|
7. |
Ghasemi A, Nadali F, Chahardouli B, Ghandforosh NA, Zadeh AG, Rostami S. Study of correlation between SFRP-1 and SFRP-2 hypermethylation with relapse, complete remission, genetic mutations of FLT3-ITD and NPM1 and immunophenotypes of leukemic cells in patients with de novo acute myeloblastic leukemia. J Hematol 2014;3:34-42.
|
8. |
Ghasemi A, Ghotaslou A, Mohammadi M, Abbasian S, Ghaffari K. Methylation of the Wnt signaling antagonist, Wnt inhibitory factor 1 and dickkopf-1 genes in acute myeloid leukemia at the time of diagnosis. Zahedan J Res Med Sci 2016;18:1-6.
|
9. |
Ghasemi A, Ghotaslou A, Ghaffari K, Mohammadi M. Methylation status of SOX17 and RUNX3 genes in acute leukemia. Iran J Blood Cancer 2015;7:213-9.
|
10. |
Ghasemi A, Ghotaslou A, Mohammadi M, Ghaffari K, Abbasian S. Dysregulation of the WNT signaling pathway through methylation of Wnt inhibitory factor 1 and dickkopf-1 genes among AML patients at the time of diagnosis. Iran J Blood Cancer 2014;7:11-7.
|
11. |
Ofran Y, Izraeli S. BCR-ABL (Ph)-like acute leukemia-pathogenesis, diagnosis and therapeutic options. Blood Rev 2017;31:11-6.
|
12. |
Ghaffari K, Ghasemi A, Mohammadi M, Abbasian S. Comparison of secreted frizzled-related protein-4 &-5 promoter methylation in patients with acute myeloblastic leukemia and healthy individuals. Iran J Blood Cancer 2021;13:1-5.
|
13. |
Vora A, Goulden N, Wade R, Mitchell C, Hancock J, Hough R, et al. Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): A randomised controlled trial. Lancet Oncol 2013;14:199-209.
|
14. |
Veringa SJ, van Dulmen-den Broeder E, Kaspers GJ, Veening MA. Blood pressure and body composition in long-term survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2012;58:278-82.
|
15. |
Levy E, Samoilenko M, Morel S, England J, Amre D, Bertout L, et al. Cardiometabolic risk factors in childhood, adolescent and young adult survivors of acute lymphoblastic leukemia – A petale cohort. Sci Rep 2017;7:17684.
|
16. |
Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham heart study: A cohort study. Lancet 2001;358:1682-6.
|
17. |
Gostynski M, Gutzwiller F, Kuulasmaa K, Döring A, Ferrario M, Grafnetter D, et al. Analysis of the relationship between total cholesterol, age, body mass index among males and females in the WHO MONICA Project. Int J Obes Relat Metab Disord 2004;28:1082-90.
|
18. |
Dossus L, Kaaks R. Nutrition, metabolic factors and cancer risk. Best Pract Res Clin Endocrinol Metab 2008;22:551-71.
|
19. |
Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al. Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss: An update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006;113:898-918.
|
20. |
Jarfelt M, Lannering B, Bosaeus I, Johannsson G, Bjarnason R. Body composition in young adult survivors of childhood acute lymphoblastic leukaemia. Eur J Endocrinol 2005;153:81-9.
|
21. |
Oeffinger KC, Mertens AC, Sklar CA, Yasui Y, Fears T, Stovall M, et al. Obesity in adult survivors of childhood acute lymphoblastic leukemia: A report from the childhood cancer survivor study. J Clin Oncol 2003;21:1359-65.
|
22. |
Gurney JG, Ness KK, Sibley SD, O'Leary M, Dengel DR, Lee JM, et al. Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer 2006;107:1303-12.
|
23. |
Van Dongen-Melman JE, Hokken-Koelega AC, Hählen K, De Groot A, Tromp CG, Egeler RM. Obesity after successful treatment of acute lymphoblastic leukemia in childhood. Pediatr Res 1995;38:86-90.
|
24. |
Garmey EG, Liu Q, Sklar CA, Meacham LR, Mertens AC, Stovall MA, et al. Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: A report from the childhood cancer survivor study. J Clin Oncol 2008;26:4639-45.
|
25. |
Nottage KA, Ness KK, Li C, Srivastava D, Robison LL, Hudson MM. Metabolic syndrome and cardiovascular risk among long-term survivors of acute lymphoblastic leukaemia – From the St. Jude Lifetime Cohort. Br J Haematol 2014;165:364-74.
|
26. |
Koch VH, Colli A, Saito MI, Furusawa EA, Ignes E, Okay Y, et al. Comparison between casual blood pressure and ambulatory blood pressure monitoring parameters in healthy and hypertensive adolescents. Blood Press Monit 2000;5:281-9.
|
27. |
Baillargeon J, Langevin AM, Lewis M, Grady JJ, Thomas PJ, Mullins J, et al. Therapy-related changes in body size in Hispanic children with acute lymphoblastic leukemia. Cancer 2005;103:1725-9.
|
28. |
Dalton VK, Rue M, Silverman LB, Gelber RD, Asselin BL, Barr RD, et al. Height and weight in children treated for acute lymphoblastic leukemia: Relationship to CNS treatment. J Clin Oncol 2003;21:2953-60.
|
29. |
Frese EM, Fick A, Sadowsky HS. Blood pressure measurement guidelines for physical therapists. Cardiopulm Phys Ther J 2011;22:5-12.
|
30. |
World Health Organization. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension: Guidelines subcommittee. J Hypertens 1999;17:151-83.
|
31. |
Chow EJ, Pihoker C, Hunt K, Wilkinson K, Friedman DL. Obesity and hypertension among children after treatment for acute lymphoblastic leukemia. Cancer 2007;110:2313-20.
|
32. |
Falkner B, Daniels SR. Summary of the fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Hypertension 2004;44:387-8.
|
33. |
Nuver J, Smit AJ, Postma A, Sleijfer DT, Gietema JA. The metabolic syndrome in long-term cancer survivors, an important target for secondary preventive measures. Cancer Treat Rev 2002;28:195-214.
|
34. |
Whitaker RC, Wright JA, Pepe MS, Seidel KD, Dietz WH. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med 1997;337:869-73.
|
35. |
Lauer RM, Clarke WR. Childhood risk factors for high adult blood pressure: The Muscatine Study. Pediatrics 1989;84:633-41.
|
36. |
Menghetti E, Strisciuglio P, Spagnolo A, Carletti M, Paciotti G, Muzzi G, et al. Hypertension and obesity in Italian school children: The role of diet, lifestyle and family history. Nutr Metab Cardiovasc Dis 2015;25:602-7.
|
37. |
Xi B, Li H, Li S, Mi J. Recent prevalence of hypertension among Chinese children and adolescents based on 2010 China national blood pressure references. Int J Cardiol 2014;174:870-1.
|
38. |
Moradmand S, Ganji MR, Meysami AP, Akbari Z, Mirkhani SZ, Tabrizchi N, et al. Prevalence of hypertension and its impact on birth weight and current body weight in school children in Tehran. J Payavard Salamat 2012;5:16-23.
|
39. |
Kelishadi R, Razaghi EM, Gouya MM, Ardalan G, Gheiratmand R, Delavari A, et al. Association of physical activity and the metabolic syndrome in children and adolescents: CASPIAN study. Horm Res Paediatr 2007;67:46-52.
|
40. |
Ociepa T, Bartnik M, Zielezińska K, Urasiński T. Prevalence and risk factors for arterial hypertension development in childhood acute lymphoblastic leukemia survivors. J Pediatr Hematol Oncol 2019;41:175-80.
|
41. |
Esbenshade AJ, Simmons JH, Koyama T, Koehler E, Whitlock JA, Friedman DL. Body mass index and blood pressure changes over the course of treatment of pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer 2011;56:372-8.
|
42. |
Oeffinger KC. Are survivors of acute lymphoblastic leukemia (ALL) at increased risk of cardiovascular disease? Pediatr Blood Cancer 2008;50:462-7.
|
43. |
Meacham LR, Chow EJ, Ness KK, Kamdar KY, Chen Y, Yasui Y, et al. Cardiovascular risk factors in adult survivors of pediatric cancer – A report from the childhood cancer survivor study. Cancer Epidemiol Prev Biomarkers 2010;19:170-81.
|
44. |
Ness KK, Oakes JM, Punyko JA, Baker KS, Gurney JG. Prevalence of the metabolic syndrome in relation to self-reported cancer history. Ann Epidemiol 2005;15:202-6.
|